Tumor Regression Patterns Based on Follow-up Duration in Patients With Head and Neck Squamous Cell Carcinoma Treated With Radiotherapy or Chemoradiotherapy
Moonkyoo Kong, Seong Eon Hong
Clin Exp Otorhinolaryngol. 2015;8(4):416-421.   Published online 2015 Nov 10     DOI: https://doi.org/10.3342/ceo.2015.8.4.416
Citations to this article as recorded by Crossref logo
Utility of magnetic resonance imaging in determining treatment response and local recurrence in nasopharyngeal carcinoma treated curatively
Katherine Meng, Jeremy Tey, Francis Cho Hao Ho, Hira Asim, Timothy Cheo
BMC Cancer.2020;[Epub]     CrossRef
Prediction of pharyngocutaneous fistula and survival after salvage laryngectomy for laryngohypopharyngeal carcinoma
Yong Han Kim, Jong‐Lyel Roh, Seung‐Ho Choi, Soon Yuhl Nam, Sang Yoon Kim
Head & Neck.2019; 41(9): 3002.     CrossRef
CISD2 inhibition overcomes resistance to sulfasalazine-induced ferroptotic cell death in head and neck cancer
Eun Hye Kim, Daiha Shin, Jaewang Lee, Ah Ra Jung, Jong-Lyel Roh
Cancer Letters.2018; 432: 180.     CrossRef
Risk factors for competing non‐cancer mortality after definitive treatment for advanced‐stage head and neck cancer
Yong Han Kim, Jong‐Lyel Roh, Sung‐Bae Kim, Seung‐Ho Choi, Soon Yuhl Nam, Sang Yoon Kim
Oral Diseases.2018; 24(7): 1217.     CrossRef
Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer
Daiha Shin, Eun Hye Kim, Jaewang Lee, Jong-Lyel Roh
Free Radical Biology and Medicine.2018; 129: 454.     CrossRef
Tumor regression patterns by follow-up duration in patients with nasopharyngeal carcinoma treated with concurrent chemoradiotherapy
Moonkyoo Kong, Seong Eon Hong
Journal of Radiation Research.2017; 58(2): 232.     CrossRef
Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis
Jong-Lyel Roh, Eun Hye Kim, Hyejin Jang, Daiha Shin
Redox Biology.2017; 11: 254.     CrossRef
Aspirin plus sorafenib potentiates cisplatin cytotoxicity in resistant head and neck cancer cells through xCT inhibition
Jong-Lyel Roh, Eun Hye Kim, Hyejin Jang, Daiha Shin
Free Radical Biology and Medicine.2017; 104: 1.     CrossRef
Postdiagnostic use of β-blockers and other antihypertensive drugs and the risk of recurrence and mortality in head and neck cancer patients: an observational study of 10,414 person–years of follow-up
S.-A. Kim, H. Moon, J.-L. Roh, S.-B. Kim, S.-H. Choi, S. Y. Nam, S. Y. Kim
Clinical and Translational Oncology.2017; 19(7): 826.     CrossRef
18F-FDG PET/CTvs. human papillomavirus, p16 and Epstein-Barr virus detection in cervical metastatic lymph nodes for identifying primary tumors
Gi Cheol Park, Jong-Lyel Roh, Kyung-Ja Cho, Jae Seung Kim, Mi Hyeon Jin, Seung-Ho Choi, Soon Yuhl Nam, Sang Yoon Kim
International Journal of Cancer.2017; 140(6): 1405.     CrossRef
RITA plus 3-MA overcomes chemoresistance of head and neck cancer cells via dual inhibition of autophagy and antioxidant systems
Daiha Shin, Eun Hye Kim, Jaewang Lee, Jong-Lyel Roh
Redox Biology.2017; 13: 219.     CrossRef
Hederagenin Induces Apoptosis in Cisplatin-Resistant Head and Neck Cancer Cells by Inhibiting the Nrf2-ARE Antioxidant Pathway
Eun Hye Kim, Seungho Baek, Daiha Shin, Jaewang Lee, Jong-Lyel Roh
Oxidative Medicine and Cellular Longevity.2017; 2017: 1.     CrossRef
Noncancer-Related Health Events and Mortality in Head and Neck Cancer Patients After Definitive Radiotherapy
Ho-Seob Kang, Jong-Lyel Roh, Sung-Bae Kim, Seung-Ho Choi, Soon Yuhl Nam, Sang Yoon Kim
Medicine.2016; 95(19): e3403.     CrossRef
Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer
Jong-Lyel Roh, Eun Hye Kim, Hye Jin Jang, Jin Young Park, Daiha Shin
Cancer Letters.2016; 381(1): 96.     CrossRef
Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer
Eun Hye Kim, Hyejin Jang, Daiha Shin, Seung Ho Baek, Jong-Lyel Roh
Apoptosis.2016; 21(11): 1265.     CrossRef